SHAUNTE WILKS: Open Payments
NPI 1477093706 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,447 in 108 payments from 21 companies in 2025. Trend: 2023 $1,003 · 2024 $2,815 · 2025 $2,447
Food & beverage: $2,447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $461 |
| LEO Pharma Inc. | 12 | $304 |
| Novartis Pharmaceuticals Corporation | 14 | $289 |
| Regeneron Healthcare Solutions, Inc. | 5 | $198 |
| UCB, Inc. | 7 | $187 |
| Janssen Biotech, Inc. | 8 | $177 |
| Amgen Inc. | 7 | $159 |
| GENZYME CORPORATION | 4 | $144 |
| Incyte Corporation | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
Products named: DUPIXENT, ADBRY, SKYRIZI, Bimzelx, TREMFYA, RINVOQ, OTEZLA, OPZELURA.
Industry payments across FL — which companies pay providers there.
